ÂÜÀòÂÒÂ×

Andreas Jurgeit is currently a Partner at Gimv and serves as a Board Member at Mediar Therapeutics and ImmunOs Therapeutics AG. Andreas also works as a Coach and Lecturer at Innosuisse - Schweizerische Agentur für Innovationsförderung, where Andreas coaches startups on topics such as financing & strategy. Additionally, Andreas is a Lecturer at ETH Zurich / IFJ start-up essentials and was previously a Partner at Lundbeckfonden Emerge. Andreas's previous roles also include serving as a Board Member at DNA Script and Indi Molecular, Inc., as well as a Director at Merck Ventures. Andreas holds a PhD in Molecular Cell Biology & Virology from the University of Zürich and a Master of Science (MSc) in Molecular Biology / Biochemistry from the University of Innsbruck.